You have access
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer
KYOICHI KAIRA, HISAO IMAI, RYOUSUKE SOUMA, REIKO SAKURAI, YOSUKE MIURA, NORIAKI SUNAGA, NORIMITSU KASAHARA, YUSUKE TSUKAGOSHI, YASUHIKO KOGA, SHINSUKE KITAHARA, MIE KOTAKE, KOICHI MINATO, ICHIRO NARUSE, YASUTSUGU FUKUSHIMA, TAKESHI HISADA and TAMOTSU ISHIZUKA
Anticancer Research May 2019, 39 (5) 2483-2491; DOI: https://doi.org/10.21873/anticanres.13368